Chronix Biomedical Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50.1M

Chronix Biomedical General Information

Description

Operator of a molecular diagnostics company intended to develop blood tests that help to see if the cancer treatment is effective or if a transplanted organ is being accepted by the patient's body or not. The company's blood test comprises diagnostics test kits that are used for the detection and monitoring of various stages of chronic diseases in human beings and animals, enabling healthcare professionals to easily detect cancer symptoms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5941 Optical Court
  • Suite 201
  • San Jose, CA 95138
  • United States
+1 (408)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 5941 Optical Court
  • Suite 201
  • San Jose, CA 95138
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chronix Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 19-Apr-2021 $50.1M Completed Profitable
15. Later Stage VC 20-Sep-2019 Completed Profitable
14. Later Stage VC (Series K) 18-Jul-2017 Completed Profitable
13. Accelerator/Incubator Completed Profitable
12. Later Stage VC (Series J) 18-May-2017 Completed Profitable
11. Later Stage VC (Series I) 31-Oct-2016 Completed Profitable
10. Later Stage VC (Series H) 08-Apr-2014 Completed Profitable
9. Later Stage VC (Series G) 30-Oct-2012 Completed Profitable
8. Later Stage VC (Series F) 11-Mar-2011 $3M $16.3M Completed Profitable
7. Later Stage VC (Series E) 31-May-2010 $1.74M $13.3M Completed Profitable
To view Chronix Biomedical’s complete valuation and funding history, request access »

Chronix Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series K
Series J
Series I
Series H
Series G
Series F
Series E
Series D
Series C 1,877,778 $0.000100 8% $0.45 $0.45 1x $0.15 2.42%
Series B 5,045,118 $0.000100 8% $0.45 $0.45 1x $0.34 2.86%
To view Chronix Biomedical’s complete cap table history, request access »

Chronix Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a molecular diagnostics company intended to develop blood tests that help to see if the cancer treatment is
Laboratory Services (Healthcare)
San Jose, CA
10 As of 2010

Birmingham, AL
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chronix Biomedical Competitors (20)

One of Chronix Biomedical’s 20 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CirculoGene Venture Capital-Backed Birmingham, AL
ROCA Test Formerly VC-backed Cambridge, United Kingdom
Foundation Medicine Formerly VC-backed Boston, MA
Myriad Genetics Corporation Salt Lake City, UT
Igenomix USA Formerly PE-Backed Paterna, Spain
You’re viewing 5 of 20 competitors. Get the full list »

Chronix Biomedical Patents

Chronix Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4409031-A1 Methods for bias-free quantification of rna Pending 29-Sep-2021
EP-4409031-A4 Methods for bias-free quantification of rna Pending 29-Sep-2021
US-20240401120-A1 Methods for bias-free quantification of rna Pending 29-Sep-2021
WO-2023055824-A1 Methods for bias-free quantification of rna Inactive 29-Sep-2021
EP-4127214-A2 Methods for precise and bias-free quantification of cell-free dna Pending 27-Mar-2020 C12Q1/686
To view Chronix Biomedical’s complete patent history, request access »

Chronix Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chronix Biomedical Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Accelerator Venture Capital Minority
Boston Harbor Angels Angel Group Minority
Bundesministerium für Bildung und Forschung Government
Angel (individual) Minority
Keiretsu Forum Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

Chronix Biomedical FAQs

  • When was Chronix Biomedical founded?

    Chronix Biomedical was founded in 1997.

  • Where is Chronix Biomedical headquartered?

    Chronix Biomedical is headquartered in San Jose, CA.

  • What is the size of Chronix Biomedical?

    Chronix Biomedical has 10 total employees.

  • What industry is Chronix Biomedical in?

    Chronix Biomedical’s primary industry is Laboratory Services (Healthcare).

  • Is Chronix Biomedical a private or public company?

    Chronix Biomedical is a Private company.

  • What is the current valuation of Chronix Biomedical?

    The current valuation of Chronix Biomedical is .

  • What is Chronix Biomedical’s current revenue?

    The current revenue for Chronix Biomedical is .

  • How much funding has Chronix Biomedical raised over time?

    Chronix Biomedical has raised $31M.

  • Who are Chronix Biomedical’s investors?

    Atlas Accelerator, Boston Harbor Angels, Bundesministerium für Bildung und Forschung, , and Keiretsu Forum are 5 of 11 investors who have invested in Chronix Biomedical.

  • Who are Chronix Biomedical’s competitors?

    CirculoGene, ROCA Test, Foundation Medicine, Myriad Genetics, and Igenomix USA are some of the 20 competitors of Chronix Biomedical.

  • When was Chronix Biomedical acquired?

    Chronix Biomedical was acquired on 19-Apr-2021.

  • Who acquired Chronix Biomedical?

    Chronix Biomedical was acquired by Insight Molecular Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process